---
title: "cellHigh — Publisher Overview"
type: publisher
publisher: "cellHigh"
publisher_slug: "cellhigh"
canonical_url: "https://marlvel.ai/publishers/cellhigh"
last_updated: 2026-05-07T06:19:11.131Z
source: Marlvel.ai
license: CC-BY-NC-4.0
citation: "Marlvel.ai — cellHigh Publisher Overview"
---
## ⚠ Content Warning

This publisher's portfolio includes apps classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This overview touches health-related apps. It is not medical advice.

---

# cellHigh — Publisher Overview

> Providing specialized symptom tracking tools for individuals managing chronic health conditions. Enabling data-driven health monitoring through symptom, trigger, and lifestyle logging.

- **Publisher:** cellHigh
- **Website:** [https://cellhigh.com](https://cellhigh.com)
- **Overview generated:** 2026-05-07
- **License:** CC-BY-NC 4.0

## Executive summary

The publisher employs a high-volume, niche-specific strategy by deploying individual tracking applications for distinct chronic conditions. By fragmenting their portfolio into condition-specific diaries, they capture long-tail search traffic for specific health concerns rather than competing in the broader, saturated general health-tracking market. The primary strategic tension lies in the high ratio of abandoned applications, suggesting a 'test-and-discard' approach to product-market fit within the health niche.

## Publisher DNA

- **Primary focus:** Health & Fitness · Symptom tracking apps
- **Scale:** studio
- **Target audience:** Individuals managing specific chronic health conditions who require granular, longitudinal data to identify symptom triggers and lifestyle correlations.

## Portfolio momentum

- **Velocity:** maintenance
- **Active apps:** 4
- **Abandoned apps:** 16
- **Last major release:** 53 days ago

With 16 of 20 apps categorized as abandoned and only 3 releases in the last 6 months, the publisher maintains a low-intensity development cycle focused on a small subset of active titles.

## Aggregated portfolio metrics

- **Total reviews (all apps):** 3,559
- **Weighted rating:** 4.40 / 5
- **Apps in portfolio:** 20

## Category breakdown

| Category | Apps | Share |
| :--- | :--- | :--- |
| Health & Fitness | 20 | 100% |

## Top apps

- **Lupus Diary 3** — Flagship app with 3,546 reviews and a 4.4 rating.
- **PCOS Diary 3** — Secondary active title with 12 reviews and a 4.11 rating.
- **Lyme Disease Diary 3** — Paid-model niche tracker with 1 review.

## Signature patterns

- High degree of portfolio fragmentation with condition-specific branding.
- Core feature set centered on trending, forecasting, and data export modules.
- Mixed monetization strategy utilizing both free and paid models across the portfolio.
- Standardized UI/UX approach applied to disparate medical conditions.

## Bottom line

The publisher operates a low-maintenance portfolio that relies on niche SEO for specific chronic conditions rather than active product innovation. Their long-term viability depends on the continued performance of their flagship Lupus tracker, as the majority of their catalog shows little evidence of ongoing support.

---
© 2026 Marlvel.ai | [Publisher apps index](https://marlvel.ai/api/llm/publishers/cellhigh) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.

---
© 2026 Marlvel.ai | [Full publisher profile](https://marlvel.ai/publishers/cellhigh) | [Publisher apps index](https://marlvel.ai/api/llm/publishers/cellhigh) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.